Home Metabolism LDH inhibitor - CDK inhibitor - Apoptosis related activator - ROS activator Sodium oxamate For research use only.

Sodium oxamate

Synonyms: SO, oxamate sodium, Aminooxoacetic acid sodium salt, Oxamic acid sodium salt

Sodium oxamate (SO, Aminooxoacetic acid, Oxamic acid) is an inhibitor of lactate dehydrogenase (LDH) that specificly inhibits LDH‑A. Sodium oxamate (SO) induces G2/M cell cycle arrest via downregulation of the CDK1/cyclin B1 pathway and promotes apoptosis through enhancement of mitochondrial ROS generation.

Sodium oxamate Chemical Structure

Sodium oxamate Chemical Structure

CAS: 565-73-1

Selleck's Sodium oxamate has been cited by 6 publications

Purity & Quality Control

Batch: Purity: 98.03%
98.03

Sodium oxamate Related Products

Choose Selective LDH Inhibitors

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
insect cells Function assay 10 mins Inhibition of human recombinant carboxy-terminal his-tagged LDHB (1 to 333) expressed in insect cells using pyruvate as substrate after 10 mins by UV endpoint analysis, IC50=33.8μM 23628333
Click to View More Cell Line Experimental Data

Biological Activity

Description Sodium oxamate (SO, Aminooxoacetic acid, Oxamic acid) is an inhibitor of lactate dehydrogenase (LDH) that specificly inhibits LDH‑A. Sodium oxamate (SO) induces G2/M cell cycle arrest via downregulation of the CDK1/cyclin B1 pathway and promotes apoptosis through enhancement of mitochondrial ROS generation.
Targets
LDHA [1] ROS [2] CDK1 [2]
In vitro
In vitro

Sodium oxamate, a specific inhibitor of LDH-A, enhances the suppressive effects of PARP inhibitors on ovarian cancer without BRCA mutations, remarkably promoting the inhibitory effects of PARP inhibitors on wild-type BRCA ovarian cancer cells.[3]
Cell Research Cell lines wild-type BRCA ovarian cancer cells (A2780 and SKOV3)
Concentrations 50 nM
Incubation Time 24 h
Method

Cell proliferation is evaluated using a Cell Counting Kit-8 (CCK-8). SKOV3 cells and A2780 cells are seeded in a 96-well culture plates at a density of 2×105 cells/well and incubated with different concentrations of the drugs (oxamate, AG14361 and olaparib) for different times. Detection reagent is added to the cells, and the luminescence signals are determined.
In Vivo
In vivo

Sodium oxamate reduces the growth of colorectal cancer in CRC mice, by restoring the down-regulated MMR functional proteins and attenuating chemotherapy resistance to oxaliplatin caused by C. tropicalis.[4]
Animal Research Animal Models four-week-old male BALB/c nude mice of CRC xenograft
Dosages 500 mg/kg
Administration i.p.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03883360 Withdrawn
Schizophrenia Spectrum Disorders|Cannabis Use
University of Maryland Baltimore|Sheppard Pratt Health System|University of California Los Angeles
 January 2050 Phase 2
NCT03643367 Not yet recruiting
Shock Septic
University of Zurich|Kantonsspital Münsterlingen|Triemli Hospital|Waid City Hospital Zurich
 January 2025 Phase 2

Chemical Information & Solubility

Molecular Weight 111.03 Formula

C2H2NNaO3
CAS No. 565-73-1 SDF --
Smiles C(=O)(C(=O)[O-])N.[Na+]
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

Water : 22 mg/mL

DMSO : Insoluble ( Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sodium oxamate | Sodium oxamate supplier | purchase Sodium oxamate | Sodium oxamate cost | Sodium oxamate manufacturer | order Sodium oxamate | Sodium oxamate distributor